Triple-negative breast cancer (TNBC), which lacks the expression of the estrogen receptor (ER), progesterone receptor (PR), and excess amplification of human epidermal growth factor receptor 2 (HER2), is the most aggressive subtype of breast cancer18,19. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.